Literature DB >> 7863140

Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women.

A Baerheim1, E Larsen, A Digranes.   

Abstract

OBJECTIVE: To examine whether vaginal application of Lactobacillus casei v. rhamnosus reduces the reinfection rate in cystitis-prone women.
DESIGN: A controlled, randomized, double-blind clinical trial.
SETTING: Division for General Practice, University of Bergen, Norway. INTERVENTION: Vaginal application of lactobacilli twice weekly.
SUBJECTS: 47 women, aged 18-50 years, reporting three or more episodes of distal urinary symptoms during the previous 12 months, of which at least one episode had been medically verified as a lower UTI. MAIN OUTCOME MEASURE: The incidence rate of lower UTI during 6 months' follow-up.
RESULTS: No difference in infection rate between the two groups; the incidence rate ratio between the treatment group and the placebo group was 1.41 (95% confidence interval 0.88-1.98). Lactobacilli were not found more frequently periurethrally in the treatment group than in the control group.
CONCLUSION: It is still uncertain whether vaginal application of lactobacilli reduces the infection rate in cystitis-prone women.

Entities:  

Mesh:

Year:  1994        PMID: 7863140     DOI: 10.3109/02813439409029247

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  19 in total

1.  Is There a Protective Role for Vaginal Flora?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women.

Authors:  Terje Alraek; Liv Inger Fosli Soedal; Siri Urnes Fagerheim; Asbjørn Digranes; Anders Baerheim
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

Review 3.  The human urinary microbiome and how it relates to urogynecology.

Authors:  Jenifer Schneeweiss; Marianne Koch; Wolfgang Umek
Journal:  Int Urogynecol J       Date:  2016-01-25       Impact factor: 2.894

Review 4.  Probiotics. Some evidence of their effectiveness.

Authors:  Gregor Reid; Jo-Anne Hammond
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

Review 5.  Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Gregoria I Betsi; Theodoros Tokas; Stavros Athanasiou
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial.

Authors:  Catherine S Forster; Michael H Hsieh; Marcos Pérez-Losada; Ljubica Caldovic; Hans Pohl; Inger Ljungberg; Bruce Sprague; Crystal Stroud; Suzanne Groah
Journal:  J Spinal Cord Med       Date:  2019-05-17       Impact factor: 1.985

7.  Probiotics to prevent the need for, and augment the use of, antibiotics.

Authors:  Gregor Reid
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

8.  Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain.

Authors:  V S Ocaña; A A Pesce De Ruiz Holgado; M E Nader-Macías
Journal:  Appl Environ Microbiol       Date:  1999-12       Impact factor: 4.792

9.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

Review 10.  The rationale for probiotics in female urogenital healthcare.

Authors:  Gregor Reid; Jeremy Burton; Estelle Devillard
Journal:  MedGenMed       Date:  2004-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.